Anti-CD123 antibodies and conjugates and derivatives thereof
TW202626720APending Publication Date: 2026-07-01IMMUNOGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114134999
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-06-07
- Filing Date
- 2016-06-29
- Publication Date
- 2026-07-01
Abstract
The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the α chain of the interleukine 3 receptor, or IL-3Rα). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.
Need to check novelty before this filing date? Find Prior Art